AbbVie Inc. (ABBV34.SA)
| Previous close | 51.39 |
| Open | 51.50 |
| Bid | 50.39 x 0 |
| Ask | 53.00 x 0 |
| Day's range | 50.45 - 53.00 |
| 52-week range | 39.68 - 57.77 |
| Volume | |
| Avg. volume | 5,753 |
| Market cap | 1.427T |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | 46.71 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.46 (2.89%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | N/A |
- Zacks
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- Zacks
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.
- The Real Deal
AbbVie CEO latest heavy hitter to buy in Boca Raton
AbbVie's Richard Gonzalez with 650 Tern Point Circle in Boca Raton (Daniel Petroni, AbbVie)AbbVie CEO Richard Gonzalez is the latest heavy hitter to buy in Boca Raton. The pharma boss dropped $14.3 million on a waterfront mansion, following a string of eight-figure deals in the city. Records show Gonzalez bought the house at 650 Tern Point Circle in Boca Raton’s […]The post AbbVie CEO latest heavy hitter to buy in Boca Raton appeared first on The Real Deal.
